VLDL R is a 130 kDa type I transmembrane protein in the LDL receptor family that plays a significant role in lipid metabolism and in nervous system development and function (1, 2). Mouse VLDL R has a 774 aa extracellular domain (ECD) (aa 25 ‑ 798) and a 54 aa cytoplasmic domain. The ECD contains eight LDLR class A repeats, three EGF‑like domains, six LDLR class B repeats, and a juxtamembrane region that is rich in O‑linked glycosylation (3, 4, 5). The cytoplasmic domain contains one NPXY internalization motif. Mouse VLDL R has at least one 105 kDa alternative splice form. This variant (termed type II VLDL R) shows an Arg substitution for aa 751 ‑ 779, and has been associated with endothelial cells (5, 6). The VLDL R expressed here corresponds to a polymorphic form that shows a Cys at position 297 of the precursor. This generates a disulfide bond in the 7th LDL class A domain that is not present when position 297 is occupied by Ser (SwissProt # P98156). The 7th domain is suggested to be a critical determinant of apoE binding to VLDL R (7). VLDL R is predominantly expressed in striated muscle, adipose tissue, brain, and endothelial cells lining capillaries and small arterioles (3, 4, 8, 9). VLDL R participates in the tissue uptake of fatty acids from plasma by mediating the internalization of ApoE‑containing lipoparticles (i.e. VLDL, beta ‑VLDL, and chylomicron remnants) (8, 10). VLDL R binds and internalizes lipoprotein lipase (LPL) and mediates its transport from the basolateral to the lumenal face of endothelial cells (9, 11). VLDL R knockout mice are characterized by reduced LPL activity, reduced serum triglyceride clearance, and a resistance to developing obesity (10, 12, 13). VLDL R influences breast cancer cell motility by mediating the uptake of uPAR‑PAI1 complexes (9, 14). Lipoprotein accumulation via macrophage VLDL R is instrumental in promoting the formation of atherosclerotic plaques (15). In the nervous system, VLDL R and ApoE R2 interactions with reelin are critical for neuronal migration and positioning in the developing brain (16). VLDL R also functions in adult hippocampal synapse maturation, synaptic plasticity, and memory formation (17, 18). The ECD of mouse VLDL R shares 95% aa sequence identity with human and rat VLDL R. Within shared regions, mouse VLDL R shares 55% and 53% aa sequence identity with ApoE R2 and LDL R, respectively.
Recombinant Mouse VLDLR (Ser297) Protein, CF
R&D Systems | Catalog # 2258-VL
Loading...
Key Product Details
- R&D Systems NS0-derived Recombinant Mouse VLDLR (Ser297) Protein (2258-VL)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
NS0
Accession Number
Applications
Binding Activity
Loading...
Product Specifications
Source
Mouse myeloma cell line, NS0-derived mouse VLDLR protein
Thr25-Ala798, with a C-terminal 10-His tag
Thr25-Ala798, with a C-terminal 10-His tag
Purity
>85%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Thr25
Predicted Molecular Mass
86.4 kDa
SDS-PAGE
130-175 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
Recombinant Mouse VLDLR (Ser297) (Catalog # 2258-VL) binds to Recombinant Mouse LRPAP (Catalog # 4480-LR) with an ED50 of 0.0100‑0.0500 μg/mL.
Recombinant Mouse VLDLR (Ser297) (Catalog # 2258-VL) binds to Recombinant Mouse LRPAP (Catalog # 4480-LR) with an ED50 of 0.0100‑0.0500 μg/mL.
Formulation, Preparation, and Storage
2258-VL
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 100 μg/mL in sterile PBS.
Loading...
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: VLDLR
References
- Qiu, S. et al. (2006) Neurobiol. Learn. Mem. 85:16.
- May, P. et al. (2005) Cell. Mol. Life Sci. 62:2325.
- Gafvels, M.E. et al. (1994) Endocrinology 135:387.
- Oka, K. et al. (1994) Eur. J. Biochem. 224:975.
- Martensen, P.M. et al. (1997) Eur. J. Biochem. 248:583.
- GenBank Accession # NP_001154892.
- Ruiz, J. et al. (2005) J. Lipid Res. 46:1721.
- Wyne, K.L. et al. (1996) Arterioscler. Thromb. Vasc. Biol. 16:407.
- Argraves, K.M. et al. (1995) J. Biol. Chem. 270:26550.
- Goudriaan, J.R. et al. (2001) Arterioscler. Thromb. Vasc. Biol. 21:1488.
- Obunike, J.C. et al. (2001) J. Biol. Chem. 276:8934.
- Yagyu, H. et al. (2002) J. Biol. Chem. 277:10037.
- Goudriaan, J.R. et al. (2004) J. Lipid Res. 45:1475.
- Webb, D.J. et al. (1999) J. Biol. Chem. 274:7412.
- van Eck, M. et al. (2005) Atherosclerosis 183:230.
- Jossin, Y. et al. (2004) J. Neurosci. 24:514.
- Niu, S. et al. (2004) Neuron 41:71.
- Weeber, E.J. et al. (2002) J. Biol. Chem. 277:39944.
Long Name
Very Low Density Lipoprotein Receptor
Alternate Names
CHRMQ1, VLDL R, VLDLRCH
Gene Symbol
VLDLR
UniProt
Additional VLDLR Products
Product Documents for Recombinant Mouse VLDLR (Ser297) Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Mouse VLDLR (Ser297) Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Mouse VLDLR (Ser297) Protein, CF
Customer Reviews for Recombinant Mouse VLDLR (Ser297) Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Mouse VLDLR (Ser297) Protein, CF and earn rewards!
Have you used Recombinant Mouse VLDLR (Ser297) Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Loading...